FI20020807A0 - Novel humanized anti-VAP-1 monoclonal antibodies - Google Patents

Novel humanized anti-VAP-1 monoclonal antibodies

Info

Publication number
FI20020807A0
FI20020807A0 FI20020807A FI20020807A FI20020807A0 FI 20020807 A0 FI20020807 A0 FI 20020807A0 FI 20020807 A FI20020807 A FI 20020807A FI 20020807 A FI20020807 A FI 20020807A FI 20020807 A0 FI20020807 A0 FI 20020807A0
Authority
FI
Finland
Prior art keywords
vap
monoclonal antibodies
humanized anti
novel humanized
novel
Prior art date
Application number
FI20020807A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Sirpa Jalkanen
Marko Salmi
Marja-Leena Laukkanen
Michael Ronald Clark
Original Assignee
Biotie Therapies Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Oyj filed Critical Biotie Therapies Oyj
Priority to FI20020807A priority Critical patent/FI20020807A0/en
Publication of FI20020807A0 publication Critical patent/FI20020807A0/en
Priority to PCT/FI2003/000330 priority patent/WO2003093319A1/en
Priority to AU2003229799A priority patent/AU2003229799A1/en

Links

FI20020807A 2002-04-29 2002-04-29 Novel humanized anti-VAP-1 monoclonal antibodies FI20020807A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI20020807A FI20020807A0 (en) 2002-04-29 2002-04-29 Novel humanized anti-VAP-1 monoclonal antibodies
PCT/FI2003/000330 WO2003093319A1 (en) 2002-04-29 2003-04-28 Novel humanized anti-vap-1 monoclonal antibody
AU2003229799A AU2003229799A1 (en) 2002-04-29 2003-04-28 Novel humanized anti-vap-1 monoclonal antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20020807A FI20020807A0 (en) 2002-04-29 2002-04-29 Novel humanized anti-VAP-1 monoclonal antibodies

Publications (1)

Publication Number Publication Date
FI20020807A0 true FI20020807A0 (en) 2002-04-29

Family

ID=8563846

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20020807A FI20020807A0 (en) 2002-04-29 2002-04-29 Novel humanized anti-VAP-1 monoclonal antibodies

Country Status (3)

Country Link
AU (1) AU2003229799A1 (en)
FI (1) FI20020807A0 (en)
WO (1) WO2003093319A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20050574A0 (en) * 2005-05-31 2005-05-31 Faron Pharmaceuticals Oy Compositions directed to amino oxidases in vivo
FI20075278A0 (en) * 2007-04-20 2007-04-20 Biotie Therapies Corp Novel completely human anti-VAP-1 monoclonal antibodies
UA112154C2 (en) * 2009-09-08 2016-08-10 Біоті Терапіс Корп. Use of vap-1 inhibitors for treating fibrotic conditions
WO2014199171A1 (en) 2013-06-12 2014-12-18 Proximagen Limited New therapeutic uses of enzyme inhibitors
WO2015189534A1 (en) 2014-06-12 2015-12-17 Proximagen Limited Vap-1 inhibitors for treating muscular dystrophy
EP3777846A1 (en) 2015-12-07 2021-02-17 BenevolentAI Cambridge Limited Vap-1 inhibitors for treating pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656906B1 (en) * 1992-06-09 1999-09-08 Oy Biotie Therapies A novel endothelial cell molecule mediating lymphocyte binding in man
WO1998053049A1 (en) * 1997-05-23 1998-11-26 Biotie Therapies Ltd. Vascular adhesion protein-1 having amine oxidase activity
GB9809951D0 (en) * 1998-05-08 1998-07-08 Univ Cambridge Tech Binding molecules

Also Published As

Publication number Publication date
WO2003093319A1 (en) 2003-11-13
AU2003229799A1 (en) 2003-11-17

Similar Documents

Publication Publication Date Title
CY2012019I1 (en) HUMAN MONOCLONAL ANTIBODIES AGAINST CD20
DE60222658D1 (en) MONOCLONAL ANTI-CD-40 ANTIBODY
DK1501856T3 (en) Anti-HER2 antibody variants
NO20054351D0 (en) Monoclonal antibody and hybridoma producing this
EE200300179A (en) Humanized anti-LT-β-R antibodies
AU2003264009A8 (en) Humanized rabbit antibodies
ATE480564T1 (en) MONOCLONAL ANTI-HUMAN TENASCIN ANTIBODY
NO20044347L (en) Anti-alfavbeta6 antibody
NO2016001I1 (en) Trastuzumab emtansin
EP1761566A4 (en) Humanized anti-tag-72 monoclonal antibodies
IL191217A (en) Humanized monoclonal anti-il-17 antibodies
DK1599504T3 (en) Modified antibody
DK1572946T3 (en) Therapeutic human monoclonal anti-IL-1R1 antibody
EP1567555A4 (en) Humanized antibodies against monocyte chemotactic proteins
BRPI0509495A2 (en) humanized antibody
EE200300569A (en) CD44v6-specific antibodies
FI20020807A0 (en) Novel humanized anti-VAP-1 monoclonal antibodies
NO20044145L (en) Assay for anti-INGAP antibodies
FI20011055A0 (en) Hevein-binding monoclonal antibodies
EP1712564A4 (en) Anti-nc1 monoclonal antibody
DE112004002660D2 (en) Human monoclonal antibody with fatliquoring effect
ATE535259T1 (en) IMMUNOGENIC MONOCLONAL ANTIBODIES
ATE506966T1 (en) HUMANIZED SUPER ANTIBODIES
IL165753A0 (en) Humanized monoclonal antibody nPAM4
AU2003236346A1 (en) Monoclonal antibody neutralizing megsin